CD8A and neoplasm: To further examine whether the increased CD8+ cells contributed to the killing effect of SHD-RT, tumor-bearing mice were injected intraperitoneally (i.p.)with three doses of anti-CD8 monoclonal antibody (10 mg/kg) immediately after SHD-RT (Figure S2C).